CME Group CME Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.88B+14.5% | $1.65B+8.1% | $1.54B-3.0% | $1.69B+10.4% | $1.64B+10.4% | ||
| $570.4M+6.8% | $629.1M+8.8% | $565M+0.9% | $562.7M+5.8% | $534.3M+1.1% | ||
| $1.31B+18.2% | $1.02B+7.7% | $972.6M-5.0% | $1.13B+12.9% | $1.11B+15.5% | ||
| 69.7%+2.2pp | 61.8%-0.3pp | 63.3%-1.4pp | 66.7%+1.5pp | 67.5%+3.0pp | ||
| $43.6M+4.6% | $43.7M+7.4% | $44M+9.5% | $44M+9.7% | $41.7M+4.5% | ||
| $201.2M+47.1% | $558.8M+274% | $204.4M+33.9% | $201M+30.6% | $136.8M-11.1% | ||
| $1.51B+21.4% | —— | $1.18B0.0% | $1.33B+15.2% | $1.24B+11.8% | ||
| $356.6M+23.6% | $395.5M+78.2% | $269M+1.9% | $305.2M+12.5% | $288.6M+11.8% | ||
| $1.17B+23.7% | $1.22B+34.3% | $896.6M-0.5% | $1.01B+16.1% | $944.2M+11.8% | ||
| 62.1%+4.6pp | 73.9%+14.4pp | 58.3%+1.4pp | 59.8%+2.9pp | 57.5%+0.7pp | ||
| $3.18+21.4% | $3.24+35.0% | $2.49-0.4% | $2.81+16.1% | $2.62+11.5% | ||
| $1.39B+22.7% | $1.05B+7.2% | $999.48M-5.1% | $1.16B+12.3% | $1.13B+14.8% | ||
| 74.1%+5.0pp | 63.5%-0.5pp | 65%-1.5pp | 68.3%+1.2pp | 69.1%+2.7pp | ||
| $1.31B+18.2% | $1.02B+7.7% | $972.6M-5.0% | $1.13B+12.9% | $1.11B+15.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CME Group's revenue?
- CME Group (CME) generated $6.8B in revenue over the trailing twelve months, up 7.5% year over year.
- Is CME Group profitable?
- CME Group reported $4.3B in net income over the trailing twelve months, a 63.6% net margin.
- What is CME Group's earnings per share?
- CME Group's diluted EPS over the trailing twelve months is $11.72.
- Where does CME Group's income statement data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
